Literature DB >> 11443208

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.

C Spitzweg1, K J Harrington, L A Pinke, R G Vile, J C Morris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443208     DOI: 10.1210/jcem.86.7.7641

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  37 in total

1.  Baculovirus vector-mediated transfer of NIS gene into colon tumor cells for radionuclide therapy.

Authors:  Hong-Yan Yin; Xiang Zhou; Hai-Fei Wu; Biao Li; Yi-Fan Zhang
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.

Authors:  Jun-Yu Zhao; Huan-Jun Wang; Hai-Peng Wang; Jin-Ming Yao; Xiao-Yun Wu; Hong-Xia Shang; Rui Zhang; Huan-Gao Zhu; Jian-Jun Dong; Lin Liao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues.

Authors:  P Fierabracci; A Pinchera; D Campani; L E Pollina; E Giustarini; C Giani
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

4.  Objective assessment of image quality VI: imaging in radiation therapy.

Authors:  Harrison H Barrett; Matthew A Kupinski; Stefan Müeller; Howard J Halpern; John C Morris; Roisin Dwyer
Journal:  Phys Med Biol       Date:  2013-11-21       Impact factor: 3.609

5.  Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Leonard Kohn; Kenneth B Ain; Gopalakrishnan M Venkataraman; Alexander Pisarchik; Jae Hoon Chung; Cesidio Giuliani; Mark Thornton; George Slugocki; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

Review 6.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

Review 7.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

8.  Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues.

Authors:  R Bruno; P Giannasio; G Ronga; E Baudin; J P Travagli; D Russo; S Filetti; M Schlumberger
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 9.  [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].

Authors:  C Spitzweg
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

Review 10.  Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.

Authors:  Sujata Narayanan; A Dimitrios Colevas
Journal:  Curr Treat Options Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.